ClinicalTrials.gov
ClinicalTrials.gov Menu

Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00003017
Recruitment Status : Completed
First Posted : April 22, 2004
Last Update Posted : June 21, 2013
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)